BioSpace News Archive

Visus Therapeutics Appoints Industry Leaders Tracy Valorie and Dwight Moxie to Board of Directors

Taysha Gene Therapies, Inc. today announced that it has been granted orphan drug designation from the European Commission for TSHA-105, an AAV9-based gene therapy in development for SLC13A5-related epilepsy.

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions, is pleased to announce initiation of in vitro studies of its recombinant human interferon alpha-2b (“rhIFN⍺2b” or “AP-003”) against the Delta variant of SARS-CoV-2.

Connect Biopharma Holdings Limited today announced that it will report financial results for the first half ended June 30, 2021 after the market closes on Tuesday, August 31, 2021.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), today announced it had enrolled the first patient in its single Phase 3 clinical trial evaluating topical roflumilast foam (ARQ-154) as a potential treatment for scalp and body psoriasis

Context Therapeutics Inc. (the “Company”), and Tyligand Bioscience, Ltd. (“Tyligand”), today announced the successful completion of ONA-XR (onapristone extended release) manufacturing process optimization pursuant to the collaboration agreement entered into between the parties in March 2020.

Rebus Biosystems, Inc . today announced Tarif Awad , a highly experienced technical and commercial leader within the world of life sciences, has joined Rebus Bio as VP Scientific Affairs.

TetraScience announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.

Scout Clinical today announced the results of their rare disease clinical trial patient focus group.

Cortexyme Presents New Data Demonstrating Evidence of P. Gingivalis Infection of the Central Nervous System in Alzheimer’s Disease at Annual Biomarkers for Alzheimer’s Disease Summit